TERAVOLT: Increased Risk of Morbidity for Patients with Lung Cancer and COVID-19 Drives Research Collaboration

… for Patients with Lung Cancer and COVID-19 Drives Research Collaboration …

Recurrence Remains a Risk Even for Patients Diagnosed via Screening

… patients when guidelines and protocols vary and more research is needed. … Recurrence Remains a Risk Even for …

Proposed Criteria for Tumor Invasion Align with Clinical Factors, Offer Better Predictability, Study Finds

… Researchers evaluating the clinical significance of …

Recurrence Remains a Risk Even for Patients Diagnosed via Screening

… immunotherapy and improved novel and targeted therapies. Research evaluating the survival benefit of early recurrence …